Lakefront Biotherapeutics American Depositary Shares (LKFT)
- Headquarters
- United States
- Employees
- 452
- Market Cap
- $1.8B
About Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
SentiSense also tracks daily options readings for Lakefront Biotherapeutics American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Lakefront Biotherapeutics American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.